Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient?

OBJECTIVE: To examine the risk of serious infection conveyed by tumour necrosis factor α (TNFα) inhibitors in the treatment of rheumatoid arthritis (RA). METHODS: Data from patients with RA enrolled in the German biologics register RABBIT were used for analysis. Baseline patient characteristics, tim...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Strangfeld, A, Eveslage, M, Schneider, M, Bergerhausen, H J, Klopsch, T, Zink, A, Listing, J
פורמט: Artigo
שפה:Inglês
יצא לאור: BMJ Group 2011
נושאים:
Clinical and Epidemiological Research
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3184240/
https://ncbi.nlm.nih.gov/pubmed/21791449
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2011.151043
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים